(Q48853545)

16 February 2018

title

L-dopa in Parkinsonism and the influence of previous thalamotomy. (English)

1 reference

16 February 2018

1 reference

parkinsonian syndrome

1 reference

Hughes RC

1

1 reference

16 February 2018

Polgar JG

series ordinal

2

1 reference

16 February 2018

Weightman D

series ordinal

3

1 reference

16 February 2018

Walton JN

series ordinal

4

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 January 1971

1 reference

16 February 2018

published in

The BMJ

1 reference

16 February 2018

volume

1

1 reference

16 February 2018

issue

5739

1 reference

16 February 2018

page(s)

7-13

1 reference

16 February 2018

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

Treatment of Parkinsonism With Levodopa

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

L-Dopa in the Treatment of Parkinsonism A Preliminary Appraisal

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

Reversal of the glabellar reflex in Parkinsonism by L-dopa

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

Modification of Parkinsonism--chronic treatment with L-dopa

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

Treatment of Parkinsonism with Laevo-Dopa

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

L-dopa in postencephalitic parkinsonism.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

On the presence of 3-hydroxytyramine in brain.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1794736

Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease

14 August 2018

1 reference

PubMed

12 December 2020

Dopamine metabolism in Parkinson's disease.

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Effects of L-dopa in Parkinson's disease.

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1136/BMJ.1.5739.7

1 reference

16 February 2018

PMCID

1794736

1 reference

16 February 2018

PubMed ID

4923653

1 reference

16 February 2018